Herbs (Global Traditional) · Native American
Echinacea (Echinacea purpurea) (Echinacea purpurea)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Echinacea primarily enhances immune function through alkylamides, which modulate macrophages via CB2 cannabinoid receptors, and polysaccharides, which boost cytokine production and phagocytosis. These actions collectively strengthen antiviral defenses and modulate inflammatory pathways.
Echinacea purpurea is a perennial herbaceous plant native to North America, commonly known as purple coneflower, belonging to the Asteraceae family. It is sourced from the aerial parts (leaves, flowers) and roots, typically extracted using methods like supercritical CO2 extraction with ethanol or maceration in 40-50% hydroalcoholic solvents.
No human clinical trials, RCTs, or meta-analyses for Echinacea purpurea were found in the provided research. The available sources focus exclusively on extraction methods, phytochemistry, and analysis techniques without any PMIDs or clinical study data.
No clinically studied dosage ranges are reported in the available research. Extracts are characterized by phenolic content (177-187 mg CAE/g total phenols, 64-70 mg/g chicoric acid in 50% ethanolic flower extracts), but these are not linked to clinical dosing. Consult a healthcare provider before starting any new supplement.
Echinacea purpurea is not consumed as a food source for macronutrient intake; its nutritional relevance lies primarily in its dense bioactive compound profile. Phenolic compounds are the dominant measurable constituents: chicoric acid (caftaric acid derivative) is the most abundant, measured at 63.66–70.31 mg/g in documented extraction studies, making it the primary marker compound. Caffeic acid derivatives are present at significant but lower concentrations, including caftaric acid and echinacoside (more concentrated in E. angustifolia roots, but present in purpurea aerial parts at approximately 0.1–0.5 mg/g). Alkamides (isobutylamides) are lipophilic bioactives found predominantly in roots at approximately 0.01–0.15% dry weight, known to interact with cannabinoid receptors CB1/CB2 in vitro. Polysaccharides including arabinogalactans and heteroglycans are present in aerial parts at roughly 1.5–3% dry weight and are water-soluble, contributing to aqueous extract activity. Glycoproteins are present at low concentrations (approximately 2–4% of dry root weight). Flavonoids including rutin, quercetin, and kaempferol glycosides are present at trace-to-moderate levels (collectively ~2–5 mg/g in aerial parts). Essential oils comprise approximately 0.1–0.5% of dry weight, containing borneol, bornyl acetate, and germacrene D. Mineral content includes modest levels of calcium, potassium, and iron, though concentrations vary by growing conditions and are not therapeutically significant at typical supplement doses. Fiber content in whole plant material is present but not quantified as a nutritional consideration. Bioavailability note: alkamides demonstrate relatively high oral bioavailability due to lipophilicity, with plasma detection confirmed in human pharmacokinetic studies; chicoric acid bioavailability is moderate and subject to gut microbiome metabolism; polysaccharides are largely non-absorbable intact and may exert local gut-level effects.
Echinacea's immunomodulatory effects stem from compounds like alkylamides, which activate CB2 cannabinoid receptors on immune cells, modulating macrophage activity, stimulating IL-10, and inhibiting TNF-α and NO. Polysaccharides enhance phagocytosis and boost production of IL-1, IL-6, and TNF-α, contributing to a robust immune response. Additionally, caffeic acid derivatives like chicoric acid scavenge free radicals and inhibit hyaluronidase, contributing to anti-inflammatory and antioxidant actions.
Modern clinical studies and pharmacological research consistently highlight Echinacea's efficacy in enhancing immune response, particularly against respiratory infections. Evidence suggests its role in reducing the duration and severity of colds and flu, with some meta-analyses supporting these findings. Its anti-inflammatory and antioxidant properties further contribute to systemic health and antiviral defenses, though specific large-scale trials on all purported benefits are ongoing. Overall, research supports its traditional use for immune support and respiratory health.
Echinacea is generally well-tolerated, with mild side effects such as gastrointestinal upset or allergic reactions, particularly in individuals sensitive to plants in the Asteraceae family. It may theoretically interact with immunosuppressant medications due to its immune-stimulating properties. Individuals with autoimmune conditions, progressive systemic diseases like multiple sclerosis or tuberculosis, and those with known allergies to ragweed or marigolds should exercise caution or avoid use. Pregnant or breastfeeding individuals should consult a healthcare provider before use due to insufficient safety data.
1 documented interactions for Echinacea (Echinacea purpurea). Click any row to read the full explanation. Always consult your healthcare provider before combining supplements with medications.
Echinacea boosts immunity while Prednisone suppresses it. Taking both defeats the purpose of your prescription.
What to do: These substances work against each other. One boosts and the other suppresses your immune system. Discuss priorities with your doctor.
Timing: Take Prednisone as prescribed. Echinacea can typically be taken with a meal at a different time. As a general rule, space botanicals 1-2 hours from prescription medications. St. John's Wort is the most interaction-prone botanical — it affects dozens of drugs via CYP enzyme induction. Always inform your prescriber about herbal supplements.
Full interaction details →Educational information only. Always consult a qualified healthcare provider before changing your supplement or medication regimen.
